NFATc1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NFATc1 monoclonal antibodies for research focused on understanding this critical transcription factor. NFATc1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NFATc1, or Nuclear Factor of Activated T-cells, cytoplasmic 1, plays a pivotal role in the immune response, particularly in T-cell activation and differentiation. NFATc1 is involved in various physiological processes, including cardiac development and bone homeostasis. Dysregulation of NFATc1 has been implicated in several diseases, making it a significant target for therapeutic intervention. Research applications include studying NFATc1 expression patterns, protein-protein interactions, and cellular localization. Investigating NFATc1 signaling pathways provides valuable insights into immune system regulation and development. Understanding NFATc1's role in disease progression helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for NFATc1 research support scientists worldwide in advancing our understanding of immune system regulation and disease mechanisms.